Upcoming events in the life science industry

RESI BostonBoston, USA,

The Redefining Early-Stage Investments (RESI) conference series brings together start-ups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek seed, series A, and B funding.

Representatives from Venture Valuation and Biotechgate will participate